Secondary Glaucoma due to Mucopolysaccharodis: a Case Report
Abstract
Introduction: Mucopolysaccharidosis (MPS) is a rare, autosomal recessive inherited lysosomal storage disorder involved in glycosaminoglycans (GAG) degradation. Glaucoma, as a leading cause of irreversible blindness, in MPS patients has a very low occurrence rate, indicating that this condition needs attention and more research to improve MPS patients’ quality of life.
Case Report: A 15-year-old boy came with a chief complaint of progressive onset of blurred vision in both eyes 4 years prior to admission. He was being treated as hypermetropia since then. Opacity was noticed in both eyes in addition to deteriorating vision for the last 3 months. Genetic test supported the possibility of MPS type VI. Hence this patient was diagnosed as secondary glaucoma due to MPS. Glaucoma medications were unable to control the intraocular pressure, thus trabeculectomy was planned. After the surgery, the patient was given antibiotic, analgetic, steroid, and anti-glaucoma medications. Releasable suture was removed on the 14th day post-surgery due to elevated IOP. Unfortunately, the patient did not make any visit afterward for further follow-up.
Discussion: Our case faces several difficulties with anterior and posterior ophthalmological examinations. Corneal opacity with corneal thickening often occurs in MPS type VI. The exact mechanisms underlying corneal opacities remain elusive. IOP measurements can be helpful for the diagnosis and monitoring of glaucoma. Changes in corneal thickness can affect IOP measurements, and corneal opacity can prevent accurate visualization of the optic nerve and cornea-sclera angle, as well as supportive diagnostic devices such as Funduscopy, Ultrasound Biomicroscopy (UBM), and Optical Coherence Tomography (OCT), are difficult to perform.
Conclusion: The underlying syndrome was suspected only after glaucoma occurred. Early detection and regular assessment play an important role in MPS. Routine follow-up is needed to ensure IOP control and determine the long-term outcome of IOP after trabeculectomy.
Keywords: Glaucoma, Mucopolysaccharidosis, trabeculectomy
Full text article
References
Al-Timimi Z, Huang-Lung J, Keay L, Healey P, Yang E, Dunn H. A Systematic Review of Glaucoma Diagnosis in Prevalence Studies and Quality of Reporting. Journal of Glaucoma. 2023 Jun 27;32(10):874–84.
Shen R, Li VSW, Wong MOM, Chan PPM. Pediatric Glaucoma—From Screening, Early Detection to Management. Children [Internet]. 2023 Feb 1 [cited 2023 Apr 23];10(2):181. Available from: https://www.mdpi.com/2227-9067/10/2/181.
Kaushik S, Singh J, Surinder Singh Pandav. Secondary developmental glaucoma. Taiwan journal of ophthalmology. 2023 Jan 1;13(4):425–33.
Kusumitha B, None M, Murugesan V, Ahmed S, Gupta N, Tandon R. Mucopolysaccharidosis. Taiwan journal of ophthalmology. 2023 Jan 1;13(4):443–50.
AAO (American Academy of Ophthalmology). Pediatric Ophthalmology and Strabismus. In: Basic and Clinical Science Course. San Fransisco: American Academy of Ophthalmology; 2020. p. 284–309.
AAO (American Academy of Ophthalmology). Glaucoma. In: Basic and Clinical Science Course. San Fransisco: American Academy of Ophthalmology; 2020. p. 202–3.
Gothwal VK, Sharma S, Mandal AK. Beyond Intraocular Pressure: Visual Functioning and Quality of Life in Primary Congenital Glaucoma and Secondary Childhood Glaucoma. Am J Ophthalmol. 2020 Jan;209:62–70.
Tomatsu S, Pitz S, Hampel U. Ophthalmological Findings in Mucopolysaccharidoses. J Clin Med. 2019 Sep 14;8(9):1467.
Spranger J. Mucopolysaccharidoses. In: Nelson Textbook of Pediatrics. 21st ed. Elsevier; 2020. p. 811–7.
Ocular Features of Mucopolysaccharidosis - EyeWiki [Internet]. Aao.org. 2023 [cited 2024 Feb 12]. Available from: https://eyewiki.aao.org/Ocular_Features_of_Mucopolysaccharidosis
Magalhães AM, Moleiro AF, Rodrigues E, Castro S, Fonseca J, Leão‐Teles E. Visual impairment in mucopolysaccharidosis VI. JIMD reports. 2023 Jan 19;64(2):129–37.
Kong W, Zhang J, Lu C, Ding Y, Meng Y. Glaucoma in mucopolysaccharidoses. Orphanet Journal of Rare Diseases. 2021 Jul 15;16(1).
AAO (American Academy of Ophthalmology). External Disease and Cornea. In: Basic and Clinical Science Course. San Fransisco: American Academy of Ophthalmology; 2020. p. 174.
Salmon JF. Kanski’s Clinical Ophthalmology E-Book: A Systematic Approach. Elsevier Health Sciences; 2019. 959 p.
AAO (American Academy of Ophthalmology). Lens and Cataract. In: Basic and Clinical Science Course. San Fransisco: American Academy of Ophthalmology; 2021. 288 p.
Temkar S, Gupta S, Sihota R, Sharma R, Angmo D, Pujari A, et al. Illuminated microcatheter circumferential trabeculotomy versus combined trabeculotomy-trabeculectomy for primary congenital glaucoma: a randomized controlled trial. Am J Ophthalmol. 2015 Mar;159(3):490-497.e2.
Refractive Surgery: 3rd edition | Dimitri T. Azar | ISBN: 9780323547697 [Internet]. Elsevier Asia Bookstore. [cited 2024 Feb 5]. Available from: https://www.asia.elsevierhealth.com/refractive-surgery-9780323547697.html
Spartalis C, Dulz S, Atiskova Y. Bilateral penetrating keratoplasty revealed advanced glaucoma in a case of mucopolysaccharidosis type VI. Journal of Case Reports and Images in Ophthalmology [Internet]. 2022 Jul 29;5(2):11–5. Available from: https://www.ijcriophthalmology.com/archive/2022/pdf/100031Z17CS2022.pdf
Yavuz OO, Ayaz E, Yildiz Y, Akgoz Karaosmanoglu A, Bulut E, Kalkanoglu Sivri HS, et al. Increased ocular wall thickness and decreased globe volume in children with mucopolysaccharidosis type VI. Diagnostic and Interventional Radiology. 2022 Oct 11;28(5):516–21.
Authors
Copyright (c) 2025 Irene Carolin Mulyadi, Franky Richard Kasih

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.